Modified T-cells are engineered with resilience genes to persist longer and function more effectively within the tumor microenvironment.

“And you know that that the way that that happens is that a patient will be selected will go in for a blood donation, give a rather large blood donation, but those cells are then shipped to a facility that Arsenal maintains. The the electroporation happens in the centralized facilities. The cells get grown up for a couple of days and tested. They get frozen down and sent back to the patient where there the cells are then thawed and they get it's the equivalent of a blood transfusion. Now their own cells have been supercharged to allow them to recognize cancer but also to have as you said added resilience, added strength in that battle against cancer.”